Skip to main content

Table 1 Summary of meningioma cases included across all papers

From: Impact of H3K27 trimethylation loss in meningiomas: a meta-analysis

 

Meningioma Cases (n,%)

 

Original Cohort

Included Cohort

H3K27me3 Retained

H3K27me3 Ambiguous

H3K27me3 Lost

Ammendola et al.

39

34 (87.2)*

27 (69.2)

0 (-)

7 (18.0)

Behling et al.

1347

1268 (94.1)*

1208 (95.2)

0 (-)

60 (4.7)

Gauchotte et al.

66

47 (71.2)*

37 (78.7)

0 (-)

10 (21.3)

Hua et al. [14]

192

192 (100)

160 (83.3)

0 (-)

32 (16.7)

Hua et al. [13]

164

164 (100)

81 (49.4)

0 (-)

83 (50.6)

Jung et al.

468

141 (30.1)*†

93 (66.0)

0 (-)

48 (34.0)

Katz et al.

232

232 (100)

194 (83.6)

13 (5.6)‡

25 (10.8)

Nassiri et al.

181

151 (83.4)*

119 (78.8)

11 (7.3)‡

21 (13.9)

Samal et al.

149

147 (98.7)*

128 (87.1)

13 (8.8)a

6 (4.1)

Total

2811

2376 (84.5)

2047 (86.1)

37 (1.6)

292 (12.3)

  1. *Reason for exclusion: inconclusive or technically unsatisfactory staining, †Reason for exclusion: age of meningioma tissue, ‡Classified as H3K27me3 retained for analysis, aCases were unused in analysis